摘要
目的:观察丹参川芎嗪对急性脑梗死患者神经功能改善情况进一步探讨丹参川芎嗪的作用机制。方法:丹参川芎嗪治疗急性脑梗死68例并与复方丹参组(对照组)进行比较。结果:丹参川芎嗪治疗急性脑梗死总有效率近95.59%,较对照组的总有效率80.95%高,且前者有明显降脂作用。结论:丹参川芎嗪疗效较复方丹参为优,且安全可靠。
OBJECTIVE In order to make an observation on neurologic function recovery of the patients with cerebral infarction, the mechanism of Salvia miltiorrhiza ＆ ligustrazine has further been inverstigated. METHODS The patients totally in the number of 131, have been randomly devided into two groups, one was salvia miltiorrhiza ＆ ligustrazine group（68 cases）, the another was Fufan Danshen group （63 cases） as a control. RESULTS It was found that total efficacy of the patients treated with salvia miltiorrhiza ＆ ligustrazine was about 95.59% which was higher than that of the control group （80. 95%） treated with Fufan Danshen. There was also an obvious effect of lowing lipids in the salvia miltiorrhiza ＆ ligustrazine group. CONCLUSION It is suggested that efficacy of salvia miltiorrhiza ＆ ligustrazine is better than Fufan Danshen.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2008年第19期1703-1704,共2页
Chinese Journal of Hospital Pharmacy
关键词
丹参川芎嗪
脑梗死
神经功能缺损评分
salviae mihiorrhizae and ligustrazine
acute cerebral Infarction
stroke impairment assessment set
